| P2093 | author name string | Lee KW | |
| | Frohlich J | |
| | Lear S | |
| | Dobiasova M | |
| P2860 | cites work | Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 |
| | Atherosclerosis — An Inflammatory Disease | Q26776972 |
| | Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group | Q27860882 |
| | The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 |
| | Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction | Q29618673 |
| | Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 |
| | Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 |
| | Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group | Q29619877 |
| | C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? | Q33678964 |
| | Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence | Q33727775 |
| | Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology | Q33740111 |
| | High density lipoproteins (HDL) and the oxidative hypothesis of atherosclerosis | Q33806840 |
| | Current perspectives on statins | Q33818381 |
| | Governance of the concentration of plasma LDL: a reevaluation of the LDL receptor paradigm | Q33829121 |
| | Markers of inflammation as predictors in cardiovascular disease | Q33853043 |
| | Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. | Q33898507 |
| | Chlamydia pneumoniae-induced atherosclerosis in a rabbit model | Q33935073 |
| | The role of folic acid in the prevention of cardiovascular disease | Q34086697 |
| | Blood levels of homocysteine and atherosclerotic vascular disease | Q34107404 |
| | The role of lipoprotein[a] in atherosclerosis | Q34107432 |
| | Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies | Q34469221 |
| | Tar yield of cigarettes and risk of acute myocardial infarction. GISSI-EFRIM Investigators | Q35188412 |
| | Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor | Q35612116 |
| | C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study | Q36598316 |
| | Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease | Q36833376 |
| | Prospective study of pathogen burden and risk of myocardial infarction or death | Q37875116 |
| | Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels | Q37875829 |
| | Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis | Q37875835 |
| | Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial | Q37876312 |
| | Lack of association between prior infection with Chlamydia pneumoniae and acute or chronic coronary artery disease | Q37878909 |
| | Detection of Chlamydia pneumoniae but not cytomegalovirus in occluded saphenous vein coronary artery bypass grafts | Q37879001 |
| | Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension | Q37879204 |
| | Infectious causes of atherosclerosis | Q37879248 |
| | Seroepidemiological evidence for an association between Chlamydia pneumoniae and atherosclerosis | Q37879495 |
| | Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation | Q37880013 |
| | Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. | Q37881308 |
| | Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group | Q37882250 |
| | Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 |
| | Murine models of Chlamydia pneumoniae infection and atherosclerosis | Q37883205 |
| | Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors | Q37886448 |
| | Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators | Q37890128 |
| | Association of Prior Infection With Chlamydia pneumoniae and Angiographically Demonstrated Coronary Artery Disease | Q37892814 |
| | Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study | Q37893723 |
| | Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis | Q39756776 |
| | Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk | Q40753513 |
| | Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men. | Q40806713 |
| | C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study | Q40828366 |
| | Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. | Q40872170 |
| | Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study | Q40873641 |
| | The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis | Q40899518 |
| | Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease | Q40913054 |
| | High density lipoproteins and coronary heart disease | Q41014702 |
| | White blood cell count and cardiovascular disease. Insights from the Framingham Study | Q41121224 |
| | Plasma concentrations of apolipoprotein A-I containing particles in normolipidaemic young men. | Q41161241 |
| | Relation of Helicobacter pylori infection and coronary heart disease | Q41333642 |
| | Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus | Q44553205 |
| | Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. | Q44689759 |
| | C-Reactive protein, serum amyloid A protein, and coronary events | Q44759100 |
| | A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study | Q45741610 |
| | Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. | Q45952917 |
| | Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise | Q47176442 |
| | Lipoprotein substrates for plasma cholesterol esterification. Influence of particle size and composition of the high density lipoprotein subfraction 3. | Q47217134 |
| | Fractional esterification rate of cholesterol in high density lipoprotein (HDL) can predict the particle size of low density lipoprotein and HDL in patients with coronary heart disease | Q47297242 |
| | Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease | Q47810201 |
| | Quantification of apolipoprotein AI-containing lipoprotein particles in non-insulin-dependent diabetes mellitus | Q47897466 |
| | Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). | Q48754609 |
| | Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators. | Q50866437 |
| | Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. | Q50866439 |
| | Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. | Q50897068 |
| | Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. | Q50950290 |
| | HDL subparticles and coronary artery disease in NIDDM. | Q50959244 |
| | Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. | Q51012002 |
| | Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. | Q51558185 |
| | Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. | Q51631986 |
| | Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. | Q52626803 |
| | The effects of running mileage and duration on plasma lipoprotein levels. | Q52874925 |
| | Haemostatic factors and prevalent coronary heart disease; the FINRISK Haemostasis Study. | Q53688840 |
| | The risk of myocardial infarction after quitting smoking in men under 55 years of age. | Q54167742 |
| | Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. | Q54286663 |
| | Mortality in relation to smoking: 20 years' observations on male British doctors | Q55032900 |
| | Passive Smoking and Heart Disease | Q56804536 |
| | Cytomegalovirus Infection and Coronary Heart Disease: Results of a German Case‐Control Study | Q57192771 |
| | Elevated Levels of Interleukin-6 in Unstable Angina | Q58230354 |
| P433 | issue | 5 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 401-440 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Critical Reviews in Clinical Laboratory Sciences | Q5186664 |
| P1476 | title | The role of risk factors in the development of atherosclerosis | |
| P478 | volume | 38 | |